Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-20 Sale |
2020-08-21 7:02 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
11,064 | $0.6476 | $7,165 | 248,936 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-31 Tax Withholding |
2021-01-05 5:12 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
37 | $2.42 | 20,307 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 8:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
312 | $0.427 | 205,728 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 8:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
1,211 | $0.427 | 646,396 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 8:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
301 | $0.427 | 167,240 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 8:20 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
628 | $0.427 | 357,926 (Direct) |
View |
| 2020-11-30 Tax Withholding |
2020-12-01 8:20 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
368 | $0.427 | 203,444 (Direct) |
View |
| 2020-10-31 Tax Withholding |
2020-11-02 7:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
312 | $0.4955 | 206,040 (Direct) |
View |
| 2020-10-31 Tax Withholding |
2020-11-02 7:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
1,211 | $0.4955 | 647,607 (Direct) |
View |
| 2020-10-31 Tax Withholding |
2020-11-02 7:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
301 | $0.4955 | 167,541 (Direct) |
View |
| 2020-10-31 Tax Withholding |
2020-11-02 7:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
628 | $0.4955 | 358,554 (Direct) |
View |
| 2020-10-31 Tax Withholding |
2020-11-02 7:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
366 | $0.4955 | 203,812 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:32 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
312 | $0.533 | 206,352 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:32 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
1,211 | $0.533 | 648,818 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:31 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
301 | $0.533 | 167,842 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:30 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
366 | $0.533 | 185,393 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:30 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
628 | $0.533 | 359,182 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-01 4:30 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
366 | $0.533 | 204,178 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:16 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
312 | $0.6194 | 206,664 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
628 | $0.6194 | 359,810 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
366 | $0.6194 | 185,759 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
301 | $0.6194 | 168,143 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
1,211 | $0.6194 | 650,029 (Direct) |
View |
| 2020-08-31 Tax Withholding |
2020-09-02 5:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
366 | $0.6194 | 204,544 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 7:04 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
27,250 | $0 | 360,438 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 7:04 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
7,761 | $0.6476 | 360,438 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 7:03 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
11,250 | $0 | 186,125 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 7:03 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
3,759 | $0.6476 | 186,125 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 7:03 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
11,250 | $0 | 204,910 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 7:03 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
3,759 | $0.6476 | 204,910 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 7:02 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
33,750 | $0 | 248,936 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 7:02 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
11,250 | $0 | 206,976 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 7:02 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
3,204 | $0.6476 | 206,976 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:57 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
366 | $0.76 | 197,419 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:56 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
628 | $0.76 | 340,949 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
366 | $0.76 | 178,634 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:08 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
301 | $0.76 | 168,444 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:08 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
1,211 | $0.76 | 651,240 (Direct) |
View |
| 2020-07-31 Tax Withholding |
2020-08-04 4:07 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary Chief Financial Officer |
312 | $0.76 | 198,930 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:56 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
52,500 | $0 | 52,500 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:55 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
52,500 | $0 | 60,500 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:55 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
52,500 | $0 | 105,500 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:54 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
52,500 | $0 | 100,140 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:54 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
52,500 | $0 | 88,500 (Direct) |
View |
| 2020-07-29 Option Award |
2020-07-31 4:53 pm |
N/A 2030-07-28 |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
52,500 | $0 | 261,250 (Direct) |
View |